Sharps Technology, Inc. (STSSW) 은(는) 상장 기업입니다 금융 섹터의 Financial - Capital Markets 산업에서 운영. 본사 소재지는 Melville, NY, 미국. 현재 CEO는 Paul Kruger Danner.
STSSW 을(를) 보유 IPO 날짜 2022-04-14, 55 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $854.75K.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
